These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8681461

  • 1. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
    Scholl P, Musser SM, Kensler TW, Groopman JD.
    Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461
    [Abstract] [Full Text] [Related]

  • 2. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
    Roebuck BD, Liu YL, Rogers AE, Groopman JD, Kensler TW.
    Cancer Res; 1991 Oct 15; 51(20):5501-6. PubMed ID: 1680553
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
    Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD.
    Cancer Res; 1987 Aug 15; 47(16):4271-7. PubMed ID: 2886217
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
    Kensler TW, Groopman JD, Eaton DL, Curphey TJ, Roebuck BD.
    Carcinogenesis; 1992 Jan 15; 13(1):95-100. PubMed ID: 1346373
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz.
    Egner PA, Gange SJ, Dolan PM, Groopman JD, Muñoz A, Kensler TW.
    Carcinogenesis; 1995 Aug 15; 16(8):1769-73. PubMed ID: 7634402
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture.
    Langouët S, Mahéo K, Berthou F, Morel F, Lagadic-Gossman D, Glaise D, Coles B, Ketterer B, Guillouzo A.
    Carcinogenesis; 1997 Jul 15; 18(7):1343-9. PubMed ID: 9230277
    [Abstract] [Full Text] [Related]

  • 11. Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat.
    Liu YL, Roebuck BD, Yager JD, Groopman JD, Kensler TW.
    Toxicol Appl Pharmacol; 1988 May 15; 93(3):442-51. PubMed ID: 3130679
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemoprevention by inducers of carcinogen detoxication enzymes.
    Kensler TW.
    Environ Health Perspect; 1997 Jun 15; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
    Roebuck BD, Curphey TJ, Li Y, Baumgartner KJ, Bodreddigari S, Yan J, Gange SJ, Kensler TW, Sutter TR.
    Carcinogenesis; 2003 Dec 15; 24(12):1919-28. PubMed ID: 14555609
    [Abstract] [Full Text] [Related]

  • 15. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
    Stresser DM, Bailey GS, Williams DE.
    Drug Metab Dispos; 1994 Dec 15; 22(3):383-91. PubMed ID: 8070314
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.
    Manson MM, Ball HW, Barrett MC, Clark HL, Judah DJ, Williamson G, Neal GE.
    Carcinogenesis; 1997 Sep 15; 18(9):1729-38. PubMed ID: 9328168
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
    Kensler TW, Gange SJ, Egner PA, Dolan PM, Muñoz A, Groopman JD, Rogers AE, Roebuck BD.
    Cancer Epidemiol Biomarkers Prev; 1997 Aug 15; 6(8):603-10. PubMed ID: 9264273
    [Abstract] [Full Text] [Related]

  • 18. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
    Takahashi N, Harttig U, Williams DE, Bailey GS.
    Carcinogenesis; 1996 Jan 15; 17(1):79-87. PubMed ID: 8565141
    [Abstract] [Full Text] [Related]

  • 19. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
    Kwak MK, Egner PA, Dolan PM, Ramos-Gomez M, Groopman JD, Itoh K, Yamamoto M, Kensler TW.
    Mutat Res; 2001 Sep 01; 480-481():305-15. PubMed ID: 11506823
    [Abstract] [Full Text] [Related]

  • 20. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM, Bammler TK, Hayes JD, Eaton DL.
    Cancer Res; 1996 May 15; 56(10):2306-13. PubMed ID: 8625305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.